Control required on outsourcing of Clinical Trials

Seattle - In the recent years it has been observed that Clinical trials are being outsourced at a faster rate by many American companies to other countries where transparency can be an issue.

Clinical Trials are patient oriented research carried out on live humans to study safety and efficacy of products under investigation.

Genetic make-up of the individual participating in the trial usually varies the response to medication and hence patients who participate in research usually should represent the pool of people that we anticipate will get benefits of the research.

Main reasons for outsourcing include economics, as the same trial can be conducted in much less value outside America. Other possible reasons can be regulatory requirements as these emerging countries have less strict regulatory requirement and diversified patient population.
Researchers at Duke University have found from new study that outsourcing clinical trials raises a variety of ethical issues.

As we progress towards advancement, Clinical research will play vital role in combating disease leading towards the health society. US Food and Drug Administration should have controlled mechanisms to crack down on overseas clinical drug trials and to ensure that new drugs sold in the U.S. are safe and effective for American consumers.